Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

Edward Mezones-Holguin, Rocio Violeta Gamboa-Cardenas, Gadwyn Sanchez-Felix, José Chávez-Corrales, Luis Miguel Helguero-Santin, L Max Laban-Seminario, Paula Alejandra Burela-Prado, Maribel Marilu Castro-Reyes, Fabian Fiestas

Research output: Contribution to journalReview article

Original languageAmerican English
JournalFrontiers in Pharmacology
Volume10
StatePublished - 8 Sep 2019

Cite this

Mezones-Holguin, E., Gamboa-Cardenas, R. V., Sanchez-Felix, G., Chávez-Corrales, J., Helguero-Santin, L. M., Laban-Seminario, L. M., Burela-Prado, P. A., Castro-Reyes, M. M., & Fiestas, F. (2019). Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country. Frontiers in Pharmacology, 10.